IL37 and atherosclerosis: In particular, IL-37 reduces inflammatory cytokines and effectively inhibits inflammation and immune responses.[148] This is achieved through suppression of proinflammatory cytokine synthesis, modulation of transcriptional cytokine expression, and prevention of kinase signaling activation.[149,150] Notably, footprints of IL-37 are observed in atherosclerosis.